Clonidine and Ototoxicity - a phase IV clinical study of FDA data

Summary:

Ototoxicity is reported only by a few people who take Clonidine.

The phase IV clinical study analyzes which people take Clonidine and have Ototoxicity. It is created by eHealthMe based on reports of 53,438 people who have side effects while taking Clonidine from the FDA, and is updated regularly.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.

On May, 18, 2022

53,438 people reported to have side effects when taking Clonidine.
Among them, 2 people (0.0%) have Ototoxicity.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 54,859 Clonidine users for its effectiveness, alternative drugs and more.

What is Ototoxicity?

Ototoxicity (damage to the ear) is found to be associated with 595 drugs and 335 conditions by eHealthMe.

Number of Clonidine and Ototoxicity reports submitted per year:

Gender of people who have Ototoxicity when taking Clonidine *:

female: 0.0 %
male: 100 %

Age of people who have Ototoxicity when taking Clonidine *:

Common drugs people take besides Clonidine *:

Common conditions people have *:

Medulloblastoma (a fast-growing, high-grade tumour that always begins in the cerebellum): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Clonidine and have Ototoxicity?

Check whether Ototoxicity is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .

Related studies

Alternative drugs to, pros and cons of Clonidine:

Clonidine (54,859 reports)

Ototoxicity treatments and more:

Ototoxicity (1,631 reports)

COVID vaccines that are related to Ototoxicity:

How severe was Ototoxicity and when was it recovered:

Ototoxicity in Clonidine

Expand to all the drugs that have ingredients of clonidine:

Ototoxicity and drugs with ingredients of clonidine (1 reports)

Common drugs associated with Ototoxicity:

Carboplatin: 234 reports
Cisplatin: 258 reports
Etoposide: 170 reports
Gentamicin: 147 reports

All the drugs that are associated with Ototoxicity:

Ototoxicity (595 drugs)

All the conditions that are associated with Ototoxicity:

Ototoxicity (335 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clonidine (the active ingredients of Clonidine) and Clonidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.